doi:urn:uuid:8e573d6c9233a410VgnVCM200000d6c1a8c0RCRDDrugmaker Merck & Co. says it will advance a new cancer drug into bigger patient tests, after promising findings in an early study against a very aggressive, common type of breast cancer.Fox Business...
With the remarkable success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells for treating haematological malignancies, there is a rapid growing interest in developing CAR-engineered NK (CAR-NK) cells for cancer therapy. Compared to CAR-T cells, CAR-NK cells could offer some ...
Multiomics Approach Suggests Positive PFS Correlation With NK Cells in NSCLC T-Cell Engagers Emerge Across Cancer Settings Tailoring Therapy in Breast Cancer Proves to Be an Elusive Goal Refined Stratification and Frontline Targeted Therapies Explored in Pediatric T-ALL Although Promising, CAR T-Ce...
US biotech firm Moderna reported promising early results from a clinical test of an experimental COVID-19 vaccine US biotech firm Moderna reported promising early results on Monday from the first clinical tests of an experimental vaccine against the novel coronavirus performed on a small number of v...
For several years, osseointegrated implant-supported overdentures have been used in the rehabilitation of full edentulism with excellent results, at least ... R.,Jacobs,A.,... - 《Clinical Oral Implants Research》 被引量: 153发表: 1992年 Evaluation of nutritional status of nonhospitalized patien...
A Chinese drugmaker is reporting positive test results for its COVID-19 pill. Early data from trials in Brazil appear promising, while more information is expected in the coming month. Suzhou-based Kintor Pharma started to develop the drug shortly after the initial outbre...
of the study was the collaboration of multiple independent experts in the areas of brain imaging and biomarkers. It is of particular interest that this treatment approach appears to be engaging basic mechanisms of resilience and integrity of the synaptic connections between brain cells," said Longo....
Promising Results In Early Trial of Novel MS TreatmentIra Flatow
WASHINGTON, April 7 (Xinhua) -- Early testing in cultured human lung and airway cells suggests that a broad-spectrum oral antiviral drug could aid the fight against COVID-19, according to a new study published on Monday. The drug, called EIDD-2801, also showed promising results against relat...
and clinical trials of NK cell infusion in patients with hematological malignancies and solid tumors have thus far yielded many encouraging clinical results. CAR-T cells have exhibited great success in treating hematological malignancies, but their drawbacks include high manufacturing costs and potentially...